Jupiter Asset Management’s AnaptysBio ANAB Stock Holding History

Jupiter Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,991	Closed	-$608K	–	500
2023 Q1	$608K	Sell	27,991 -31,776	-53%	-$772K	0.01%	365
2022 Q4	$1.85M	Hold	59,767	–	–	0.03%	319
2022 Q3	$1.52M	Hold	59,767	–	–	0.02%	365
2022 Q2	$1.21M	Sell	59,767 -681	-1%	-$15.1K	0.02%	407
2022 Q1	$1.5M	Buy	60,448 +1,494	+3%	+$45.2K	0.02%	378
2021 Q4	$2.08M	Hold	58,954	–	–	0.02%	354
2021 Q3	$1.6M	Hold	58,954	–	–	0.02%	371
2021 Q2	$1.53M	Buy	+58,954	New	+$1.41M	0.02%	404

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jupiter Asset Management's ANAB Position: Q2 2023 in Review

Jupiter Asset Management sold out of AnaptysBio (ANAB) in Q2 2023, closing a stake of 27,991 shares — an estimated $608K sold.

Jupiter Asset Management first reported a position in ANAB in Q2 2021 and held it in 8 quarters. The position peaked at $2.08M in Q4 2021. 116 funds tracked by Wall St. Rank hold ANAB as of Q2 2023.

Jupiter Asset Management reported no remaining AnaptysBio position as of Q2 2023 after selling out during the quarter.
Jupiter Asset Management sold 27,991 AnaptysBio shares in Q2 2023, an estimated $608K.
Jupiter Asset Management first reported a position in AnaptysBio in Q2 2021 and held it in 8 quarters.
Jupiter Asset Management's AnaptysBio position peaked at $2.08M in Q4 2021.
116 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2023.

Based on Jupiter Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.